These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 23268930)

  • 1. Unconventional secretion is a major contributor of cancer cell line secretomes.
    Villarreal L; Méndez O; Salvans C; Gregori J; Baselga J; Villanueva J
    Mol Cell Proteomics; 2013 May; 12(5):1046-60. PubMed ID: 23268930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioinformatic reanalysis of public proteomics data reveals that nuclear proteins are recurrent in cancer secretomes.
    De Morais JA; Zelanis A
    Traffic; 2022 Feb; 23(2):98-108. PubMed ID: 34806804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Colorectal cancer candidate biomarkers identified by tissue secretome proteome profiling.
    de Wit M; Kant H; Piersma SR; Pham TV; Mongera S; van Berkel MP; Boven E; Pontén F; Meijer GA; Jimenez CR; Fijneman RJ
    J Proteomics; 2014 Mar; 99():26-39. PubMed ID: 24418523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Secretome analysis using a hollow fiber culture system for cancer biomarker discovery.
    Chiu KH; Chang YH; Liao PC
    Biochim Biophys Acta; 2013 Nov; 1834(11):2285-92. PubMed ID: 23376430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pitfalls and opportunities in the characterization of unconventionally secreted proteins by secretome analysis.
    Schira-Heinen J; Grube L; Waldera-Lupa DM; Baberg F; Langini M; Etemad-Parishanzadeh O; Poschmann G; Stühler K
    Biochim Biophys Acta Proteins Proteom; 2019 Dec; 1867(12):140237. PubMed ID: 31202002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of ganglioside GM2 activator playing a role in cancer cell migration through proteomic analysis of breast cancer secretomes.
    Shin J; Kim G; Lee JW; Lee JE; Kim YS; Yu JH; Lee ST; Ahn SH; Kim H; Lee C
    Cancer Sci; 2016 Jun; 107(6):828-35. PubMed ID: 27002480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Secreted proteins as a fundamental source for biomarker discovery.
    Stastna M; Van Eyk JE
    Proteomics; 2012 Feb; 12(4-5):722-35. PubMed ID: 22247067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Secretome protein signature of human pancreatic cancer stem-like cells.
    Brandi J; Dalla Pozza E; Dando I; Biondani G; Robotti E; Jenkins R; Elliott V; Park K; Marengo E; Costello E; Scarpa A; Palmieri M; Cecconi D
    J Proteomics; 2016 Mar; 136():1-12. PubMed ID: 26850699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteome analysis of non-small cell lung cancer cell line secretomes and patient sputum reveals biofluid biomarker candidates for cisplatin response prediction.
    Böttger F; Schaaij-Visser TB; de Reus I; Piersma SR; Pham TV; Nagel R; Brakenhoff RH; Thunnissen E; Smit EF; Jimenez CR
    J Proteomics; 2019 Mar; 196():106-119. PubMed ID: 30710758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cancer secretome, current status and opportunities in the lung, breast and colorectal cancer context.
    Schaaij-Visser TB; de Wit M; Lam SW; Jiménez CR
    Biochim Biophys Acta; 2013 Nov; 1834(11):2242-58. PubMed ID: 23376433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In silico approach to predict pancreatic β-cells classically secreted proteins.
    Pinheiro-Machado E; Milkewitz Sandberg TO; Pihl C; Hägglund PM; Marzec MT
    Biosci Rep; 2020 Feb; 40(2):. PubMed ID: 32003782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Challenges and opportunities for cell line secretomes in cancer proteomics.
    Méndez O; Villanueva J
    Proteomics Clin Appl; 2015 Apr; 9(3-4):348-57. PubMed ID: 25418557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stable Isotope Dynamic Labeling of Secretomes (SIDLS) Identifies Authentic Secretory Proteins Released by Cancer and Stromal Cells.
    Hammond DE; Kumar JD; Raymond L; Simpson DM; Beynon RJ; Dockray GJ; Varro A
    Mol Cell Proteomics; 2018 Sep; 17(9):1837-1849. PubMed ID: 29915148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteomic approaches to decipher cancer cell secretome.
    Brandi J; Manfredi M; Speziali G; Gosetti F; Marengo E; Cecconi D
    Semin Cell Dev Biol; 2018 Jun; 78():93-101. PubMed ID: 28684183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Proteomic Analysis of the Malignant Mesothelioma Secretome Using iTRAQ.
    Creaney J; Dick IM; Leon JS; Robinson BW
    Cancer Genomics Proteomics; 2017; 14(2):103-117. PubMed ID: 28387650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanonets Collect Cancer Secretome from Pericellular Space.
    Zhou R; Kuang Y; Zhou J; Du X; Li J; Shi J; Haburcak R; Xu B
    PLoS One; 2016; 11(4):e0154126. PubMed ID: 27100780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A high-quality secretome of A549 cells aided the discovery of C4b-binding protein as a novel serum biomarker for non-small cell lung cancer.
    Luo X; Liu Y; Wang R; Hu H; Zeng R; Chen H
    J Proteomics; 2011 Apr; 74(4):528-38. PubMed ID: 21262398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of Cancer Cell Line Secretomes: A Complementary Source of Disease-Specific Protein Biomarkers.
    Dunphy K; Bazou D; Dowling P
    Methods Mol Biol; 2023; 2645():277-287. PubMed ID: 37202627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Candidate serological biomarkers for cancer identified from the secretomes of 23 cancer cell lines and the human protein atlas.
    Wu CC; Hsu CW; Chen CD; Yu CJ; Chang KP; Tai DI; Liu HP; Su WH; Chang YS; Yu JS
    Mol Cell Proteomics; 2010 Jun; 9(6):1100-17. PubMed ID: 20124221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteomic Profiling of Secreted Proteins, Exosomes, and Microvesicles in Cell Culture Conditioned Media.
    Sinha A; Principe S; Alfaro J; Ignatchenko A; Ignatchenko V; Kislinger T
    Methods Mol Biol; 2018; 1722():91-102. PubMed ID: 29264800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.